JPSCR : Journal of Pharmaceutical Science and Clinical Research
Vol 1, No 1 (2016)

AN OVERVIEW OF HIV TREATMENTS: WHAT TO START

Vinci Mizranita (Pharmacy Department, Sebelas Maret University)



Article Info

Publish Date
09 Mar 2016

Abstract

Combinations of HAART using 2 NRTIs plus NNRTIs or PIs (zidovudine, abacavir or tenofovir plus lamivudine, or emtricitabine plus tenofovir) are preferred treatment of HIV infection internationally and in Australia.Some antiretroviral should not be combined due to overlapping toxicities and potential viral antagonism (e.g. Atazanavir + indinavir, didanosine + stavudine). The challenges for treating HIV infection will be to reduce adverse effects, drug resistance, and increased options for treatment-experienced patients (HIV patient with previously treated using ARV).

Copyrights © 2016






Journal Info

Abbrev

jpscr

Publisher

Subject

Environmental Science Public Health

Description

Journal of Pharmaceutical Science And Clinical Research (e-ISSN 2503-331x) offers a forum for publishing the original research articles, review articles from contributors, and the novel technology news related to pharmaceutical science and clinical research. Scientific articles dealing with natural ...